Shandong New Time Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is SEVOFLURANE USP, with a corresponding US DMF Number 22740.
Remarkably, this DMF maintains an Active status since its submission on April 20, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 09, 2019, and payment made on September 27, 2019, indicating their dedication to facilitating drug approvals, Categorized as Type II